TR199802705T2 - Progestojen-anti-progestojen kürü - Google Patents
Progestojen-anti-progestojen kürüInfo
- Publication number
- TR199802705T2 TR199802705T2 TR1998/02705T TR9802705T TR199802705T2 TR 199802705 T2 TR199802705 T2 TR 199802705T2 TR 1998/02705 T TR1998/02705 T TR 1998/02705T TR 9802705 T TR9802705 T TR 9802705T TR 199802705 T2 TR199802705 T2 TR 199802705T2
- Authority
- TR
- Turkey
- Prior art keywords
- progestogen
- progestogens
- hrt
- estrogen
- cycle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Glass Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Bir gebelikten korunma ve/veya HRT (hormon degistirme tedavisi) takimi olup, herbirinin tek bir gebelikten koruma için etkili etken madde olarak progestojen içeren veya HRT için etkili etken madde olarak estrojenli veya estrojensiz progestojen veya sadece estrojen içeren ve ayrica bir veya birden fazla dozaj biriminin anti-progestojen içerdigi sirali günlük dozaj birimlerinden olusur. Anti-progestojenin biri baslangiçta uygulanir ve digerleri de dönem içinde düzenli olarak bölünür, tercihen, sadece bir tanesi dönemin ortasinda uygulanir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96201744 | 1996-06-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199802705T2 true TR199802705T2 (tr) | 1999-03-22 |
Family
ID=8224104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR1998/02705T TR199802705T2 (tr) | 1996-06-25 | 1997-06-23 | Progestojen-anti-progestojen kürü |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0912186B1 (tr) |
JP (1) | JP2000514785A (tr) |
KR (1) | KR20000022189A (tr) |
AT (1) | ATE213947T1 (tr) |
AU (1) | AU725670B2 (tr) |
BR (1) | BR9709934A (tr) |
CA (1) | CA2255863A1 (tr) |
CZ (1) | CZ290697B6 (tr) |
DE (1) | DE69710896T2 (tr) |
ES (1) | ES2174265T3 (tr) |
HK (1) | HK1019305A1 (tr) |
NO (1) | NO986104L (tr) |
NZ (1) | NZ332894A (tr) |
PL (1) | PL330916A1 (tr) |
RU (1) | RU2189819C2 (tr) |
TR (1) | TR199802705T2 (tr) |
WO (1) | WO1997049407A1 (tr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0100542A3 (en) | 1997-11-14 | 2001-10-29 | Akzo Nobel Nv | Progestogen and antiprogestogen containing kit, process for its preparation and use of the compounds for the preparation of contraseptives |
ATE277618T1 (de) * | 1999-04-29 | 2004-10-15 | Akzo Nobel Nv | Verwendung von org 33245 in der kombinierten intermittierenden hormontherapie und empfängnisverhütung |
US6498154B1 (en) * | 1999-05-04 | 2002-12-24 | Wyeth | Cyclic regimens using quinazolinone and benzoxazine derivatives |
US6369056B1 (en) | 1999-05-04 | 2002-04-09 | American Home Products Corporation | Cyclic urea and cyclic amide derivatives |
US6380178B1 (en) * | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Cyclic regimens using cyclocarbamate and cyclic amide derivatives |
US6444668B1 (en) | 1999-05-04 | 2002-09-03 | Wyeth | Combination regimens using progesterone receptor modulators |
US6509334B1 (en) | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
WO2000066168A1 (en) * | 1999-05-04 | 2000-11-09 | American Home Products Corporation | Compositions containing benzimidazolones and progestogens |
US6358947B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Tetracyclic progesterone receptor modulator compounds and methods |
US6339098B1 (en) | 1999-05-04 | 2002-01-15 | American Home Products Corporation | 2,1-benzisothiazoline 2,2-dioxides |
US6319912B1 (en) | 1999-05-04 | 2001-11-20 | American Home Products Corporation | Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides |
US6417214B1 (en) | 1999-05-04 | 2002-07-09 | Wyeth | 3,3-substituted indoline derivatives |
DE60013798T2 (de) * | 1999-05-04 | 2005-09-29 | Wyeth | Empfängnisverhütende zusammensetzungen die progestagen und progesteronantagonisten enthalten |
US6306851B1 (en) | 1999-05-04 | 2001-10-23 | American Home Products Corporation | Cyclocarbamate and cyclic amide derivatives |
US6380235B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Benzimidazolones and analogues |
US6355648B1 (en) | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
US6329416B1 (en) * | 1999-05-04 | 2001-12-11 | American Home Products Corporation | Combination regimens using 3,3-substituted indoline derivatives |
US6423699B1 (en) | 1999-05-04 | 2002-07-23 | American Home Products Corporation | Combination therapies using benzimidazolones |
US6407101B1 (en) | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
US6462032B1 (en) * | 1999-05-04 | 2002-10-08 | Wyeth | Cyclic regimens utilizing indoline derivatives |
US6391907B1 (en) | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
US6399593B1 (en) * | 1999-05-04 | 2002-06-04 | Wyeth | Cyclic regimens using cyclic urea and cyclic amide derivatives |
US6358948B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
CA2383650A1 (en) * | 1999-08-31 | 2001-04-19 | Jenapharm Gmbh & Co. Kg | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
HUP0202460A3 (en) * | 1999-08-31 | 2004-04-28 | Schering Ag | Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt) |
US7629334B1 (en) | 1999-08-31 | 2009-12-08 | Bayer Schering Pharma Aktiengesellschaft | Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT) |
UA73119C2 (en) | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
US7772219B2 (en) * | 2003-05-02 | 2010-08-10 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
TW200531977A (en) | 2004-03-25 | 2005-10-01 | Akzo Nobel Nv | Progesterone receptor modulators |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1918092A (en) * | 1992-05-06 | 1993-11-29 | Medical College Of Hampton Roads, The | Minimizing progestin associated breakthrough bleeding |
ZA935617B (en) * | 1992-08-14 | 1994-03-07 | Akzo Nv | Antiprogestogen containing contraceptives. |
DE4344463A1 (de) * | 1993-12-22 | 1995-06-29 | Schering Ag | Kombinationsprodukt zur Kontrazeption |
DK0792152T3 (da) * | 1994-11-22 | 2004-07-12 | Balance Pharmaceuticals Inc | Fremgangsmåder til svangerskabsforebyggelse |
-
1997
- 1997-06-23 AU AU34360/97A patent/AU725670B2/en not_active Ceased
- 1997-06-23 ES ES97930384T patent/ES2174265T3/es not_active Expired - Lifetime
- 1997-06-23 AT AT97930384T patent/ATE213947T1/de not_active IP Right Cessation
- 1997-06-23 WO PCT/EP1997/003288 patent/WO1997049407A1/en active IP Right Grant
- 1997-06-23 EP EP97930384A patent/EP0912186B1/en not_active Expired - Lifetime
- 1997-06-23 JP JP10502338A patent/JP2000514785A/ja not_active Ceased
- 1997-06-23 BR BR9709934A patent/BR9709934A/pt not_active IP Right Cessation
- 1997-06-23 KR KR1019980710607A patent/KR20000022189A/ko active IP Right Grant
- 1997-06-23 PL PL97330916A patent/PL330916A1/xx unknown
- 1997-06-23 CA CA002255863A patent/CA2255863A1/en not_active Abandoned
- 1997-06-23 RU RU99101114/14A patent/RU2189819C2/ru not_active IP Right Cessation
- 1997-06-23 DE DE69710896T patent/DE69710896T2/de not_active Expired - Fee Related
- 1997-06-23 TR TR1998/02705T patent/TR199802705T2/tr unknown
- 1997-06-23 CZ CZ19984289A patent/CZ290697B6/cs not_active IP Right Cessation
- 1997-06-23 NZ NZ332894A patent/NZ332894A/xx unknown
-
1998
- 1998-12-23 NO NO986104A patent/NO986104L/no not_active Application Discontinuation
-
1999
- 1999-10-07 HK HK99104372A patent/HK1019305A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20000022189A (ko) | 2000-04-25 |
HK1019305A1 (en) | 2000-02-03 |
RU2189819C2 (ru) | 2002-09-27 |
BR9709934A (pt) | 1999-08-10 |
JP2000514785A (ja) | 2000-11-07 |
PL330916A1 (en) | 1999-06-07 |
CA2255863A1 (en) | 1997-12-31 |
AU725670B2 (en) | 2000-10-19 |
NO986104D0 (no) | 1998-12-23 |
DE69710896D1 (en) | 2002-04-11 |
NO986104L (no) | 1998-12-23 |
AU3436097A (en) | 1998-01-14 |
EP0912186A1 (en) | 1999-05-06 |
WO1997049407A1 (en) | 1997-12-31 |
CZ428998A3 (cs) | 1999-08-11 |
ES2174265T3 (es) | 2002-11-01 |
ATE213947T1 (de) | 2002-03-15 |
DE69710896T2 (de) | 2002-09-26 |
CZ290697B6 (cs) | 2002-09-11 |
NZ332894A (en) | 1999-05-28 |
EP0912186B1 (en) | 2002-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199802705T2 (tr) | Progestojen-anti-progestojen kürü | |
ATE239483T1 (de) | Pharmazeutisches kombinationspräparat, kit und methode zur hormonalen kontrazeption | |
FI903106A0 (fi) | Preventivsystem och -foerfarande. | |
DK0836506T3 (da) | Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen | |
NO982902D0 (no) | FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen | |
KR960706344A (ko) | 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne) | |
ATE136218T1 (de) | Orales kontrazeptin mit niedrigem östrogen- enthalt | |
BG101553A (en) | Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives | |
NZ333750A (en) | Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
BG101427A (en) | Competitive progesterone antagonists for regulating female fertility as required | |
NZ504351A (en) | Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen | |
HUP9903097A2 (hu) | Progesztogén-antiprogesztogén tartalmú gyógyszerkészítmény | |
MX9707009A (es) | Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas. |